Treatment of multiple eccrine hydrocystomas with botulinum toxin type-A (BT-A)
Not Applicable
- Conditions
- multiple eccrine hydrocystomas.Other eccrine sweat disorders
- Registration Number
- IRCT201105316403N2
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
pathologically documented
Exclusion criteria: previous sensitivity to Buttox, Each muscular weakness such as myastina gravis, simultaneous use of any drugs induced muscular weakness
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement. Timepoint: The end of 2th week, 1th, 3th, 6th, 12th months. Method of measurement: clinical observation.
- Secondary Outcome Measures
Name Time Method Complication (ptosis, ecchymosis, facial asymetry). Timepoint: The end 2 week, 1th, 3th, 6th and 12th months. Method of measurement: clinical observation.